Ravulizumab (Ultomiris)

ravulizumab-cwvz · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ravulizumab (Ultomiris), covering 2024-08-12 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis